SOLV Q3 2024 Earnings — Solventum Corporation Revenue & Financial Results | Market Cap Arena

SOLVSolventum Corporation

$12B

Q3 2024 Earnings

Healthcare Medical - Care Facilities

Income Statement

Revenue

$2.1B+0.4% YoY

Gross Profit

$1.2B56.0% margin

Operating Income

$275M13.2% margin

Net Income

$122M5.9% margin

EPS (Diluted)

$0.70

QoQ Revenue Growth

+0.0%

Cash Flow

Operating Cash Flow

$169M

Free Cash Flow

$76M

Stock-Based Comp.

$27M

Balance Sheet

Total Assets

$14.7B

Total Liabilities

$11.6B

Stockholders' Equity

$3.2B

Cash & Equivalents

$772M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$2.1B	$2.1B	+0.4%
Gross Profit	$1.2B	$1.2B	-3.6%
Operating Income	$275M	$504M	-45.4%
Net Income	$122M	$460M	-73.5%

Revenue Segments

Product

$1.6B100%